Peptide Encyclopaedia
Melatonin
Also known as N-acetyl-5-methoxytryptamine.
Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.
At-a-glance profile
- Classification
- Indoleamine hormone (not a peptide)
- Approval status
- Approved medicine
- Research status
- Labelled indications are defined in product information.
- Molecular formula
- Insufficient reliable evidence identified.
- Molecular weight
- Insufficient reliable evidence identified.
- Sequence
- Small tryptophan metabolite; listed on peptide price sheets anyway.
- Primary biological target
- Insufficient reliable evidence identified.
- Half-life
- Insufficient reliable evidence identified.
- Routes investigated
- Insufficient reliable evidence identified.
- Human evidence level
- A — Approved clinical use / strong human evidence
What is it?
A circadian hormone available as licensed or listed oral products in some markets. Injectable ‘melatonin 10 mg vials’ are not those products and are not sold here.
Mechanism of action
MT1/MT2 receptor signalling and circadian phase-shifting.
Sleepiness, prolactin and temperature effects.
What is it being studied for?
- Jet lag / insomnia in specific licensed presentations
Investigational findings are not proven clinical benefits unless an authority has labelled that indication.
Evidence level
Overall human evidence grade: A · Approved clinical use / strong human evidence
Human research
Oral melatonin has a mixed evidence base; injectable research stock is unjustified.
Preclinical research
Animal, cell and in-vitro findings are listed separately from human effects.
Pineal hormone biology.
Doses reported in published research
This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.
Doses reported in human studies
Insufficient reliable evidence identified.
Preclinical / animal study dosing
Insufficient reliable evidence identified.
Pharmacokinetics
Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.
Safety
Next-day sedation, vivid dreams; injection adds infection risk.
Unknowns. Absence of a published harm signal is not evidence of safety.
Contraindications. Follow labelled oral products; do not inject research melatonin.
Regulatory status
Oral products may be listed/registered; injectable research melatonin is unapproved.
Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.
Citations
[1] Encyclopaedia note
Encyclopaedia note
For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.
Last reviewed 2026-09-13. Research areas: Cognitive, Healthy Ageing · Compare peptides